Abstract
Background: Diabetic patients have a greater likelihood of having dyslipidemia, hypertension, and obesity. This form of dyslipidemia remains largely undiagnosed or diagnosed late and under treated in high risk populations, such as patient with type- 2 diabetes. The aim of the study is to investigate the relationship between serum lipid profiles in type-2 diabetic patients.
Material & Methods: A cross sectional study done on 200 patients with type 2 diabetes. The participants were already diagnosed as type 2 diabetics and undergoing treatment. According to NCEP-ATPIII guideline, hypercholesterolemia is defined as TC>5.2 mmol/l, high LDL-C when value >2.6 mmol/l, hypertriglyceridemia as TG >3.8 mmol/l and low HDL-C when value <1.0 mmol/l. Dyslipidemia was defined by presence of one or more than one abnormal serum lipid concentration. Diabetes was defined as per American Diabetes Association (ADA) criteria.
Results: The mean age of the males (58.1±2.3) were not statistically different (p=0.6402) from that of the females (57.1±1). The mean waist circumference (WC), hip circumference (HC), Body Adiposity Index (BAI) and Body Mass Index (BMI) of the female subjects were significantly high as compared with the male subjects (p=0.0008, 0.0002, 0.000 and 0.0002 respectively). Among the diabetic individuals, 119(59.5%) individuals had only one abnormal lipid profile parameter, 68(34.0%) had two abnormal lipid parameter and 54(27%) individuals had more than 2 abnormal lipid profile parameter.
Conclusion: We concluded that early diagnosis can be accomplished through relatively inexpensive blood testing and may be utilized for screening high-risk diabetic patients for timely intervention with lipid lowering drugs.
Keywords: Type II Diabetes mellitus, Lipid Profile, Dyslipidemia, BMI.
References
- American Diabetes Association. Nutrition principles and recommendations in diabetes (Position Statement). Diabetes Care,2004; 27(Suppl. 1), S36–S46.
- Fauci S.A. Harrison’s Principles of Internal Medicine. 17th Edition. United States of America. The McGraw Hill Company, 2008.
- American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care,2004; 27(Suppl. 1), S68–S71.
- Masram S.W., Bimanpalli M.V. and Ghangle S. Study of Lipid Profile and Glycated Hemoglobin in Diabetes Mellitus. Indian Medical Gazette,2012.
- H.O Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation,1999 ; Report no. 99.2.
- Folsom A.R., Chambless L.E., Duncan B.B. and Gilbert A.C. Pankow JS. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 2003; 26: 2777-84.
- Patiakas S. and Charalampous C. "Correlation Between The Glycated Hemoglobin (Hba1c) Level, The Arterial Blood Pressure (AP) And The Body Mass Index (BMI) In Diabetic Patients, And Evaluation Of Its Utility As A C: Pp.17.170." Journal of Hypertension 2010; 28: e300.
- Sushil M.I., Muneshwar J.N., Khan S.T. To Study Body Mass Index, Waist Circumference, Waist Hip Ratio,Body Adiposity Index And Lipid Profile Level In Patients With Type-2 Diabetes Mellitus. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2015;Volume 14, Issue 5 Ver. III, PP 98-101.
- Ram V. M., Prajwal G., Pramod P. R., Prashant R, Khelanand P. S., Dipendra R. P. and Prabin G. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Research 2011; 22 (3): 375-380.
- Selvin E., Coresh J., Wattanakit K., Steffes M.W. and Sharrett R. HbA1c and Peripheral arterial disease in diabetes, The ARIC Study. Diabetes Care,2006; 29: 877-82.
- Gottsater A., Landin-Olsson M., Fernlund P., Lernmark A. and Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care,1993;16:902–910.
- Durrington P. and Sniderman A. Epidemiology and pathophysiology. In: Hyperlipidemia. Durrington P, Sniderman A (Eds). Health Press, Oxford, UK,2002: 71–89.
Corresponding Author
Dr Vijayta Modi
Assistant Professor, Dept. of Pathology
S.P. Medical College, Bikaner, Rajasthan, India
DOI: https://dx.doi.org/10.18535/jmscr/v6i7.13
